Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium - Ishiyama, Hiromichi; Kamitani, Nobuhiko; Kawamura, Hidemasa; Kato, Shingo; Aoki, Manabu; Kariya, Shinji; Matsumura, Taisei; Kaidu, Motoki; Yoshida, Ken; Hashimoto, Yaichiro; Noda, Yasutaka; Lim, Keith H.C.; et al. (Brachytherapy, 2017)
Keywords: Aged; Androgen Antagonists - therapeutic use; Androgen deprivation therapy; Brachytherapy; Brachytherapy - adverse effects; Chemotherapy, Adjuvant; Disease-Free Survival; Follow-Up Studies; Gastrointestinal Diseases - etiology; Hematology, Oncology and Palliative Medicine; High dose rate; Humans; Japan; Male; Male Urogenital Diseases - etiology; Middle Aged; Neoadjuvant Therapy; Prostate cancer; Prostate-Specific Antigen - blood; Prostatic Neoplasms - blood; Prostatic Neoplasms - pathology; Prostatic Neoplasms - therapy; Radiology; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Whole pelvic irradiation; Brachytherapy; Androgen deprivation therapy; Whole pelvic irradiation; Prostate cancer; High dose rate